Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Böhm

Showing results (1-10 of 1,247) with videos related to

Pageof 125
Sort By:
The American Journal of Cardiology|September 12, 2007
Angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors: where do we stand now?Michael Böhm
Herz|May 25, 2002
[Pathophysiology of heart failure today]Michael Böhm
MMW Fortschritte Der Medizin|November 8, 2003
[Therapy of heart failure. Which patients does the AT1 blocker help?]Michael Böhm
European Journal of Heart Failure|December 6, 2016
Heart rate: from heart failure to chronic diseases and cancer. Is there a role for supportive care by heart rate reduction?Michael Böhm
MMW Fortschritte Der Medizin|June 25, 2014
[Interview with Prof. Dr. med. Michael Böhm: lessons from SYMPLICITY HTN-3. "Denervation only within the scope of studies or registries" (interview by Dr. med. Dirk Einecke)]Michael Böhm
MMW Fortschritte Der Medizin|September 26, 2006
[Dyspnea in an ex-farmer]Oliver Weingärtner, Michael Böhm
Journal of the American College of Cardiology|May 31, 2011
Targeting mitochondrial oxidative stress in heart failure throttling the afterburnerChristoph Maack, Michael Böhm
MMW Fortschritte Der Medizin|March 25, 2022
[What the primary care physician can and should do initially in the practice when heart failure is suspected?]Amr Abdin, Michael Böhm
European Heart Journal|September 12, 2018
High blood pressure in coronary artery disease: when to start treating and what to target?Michael Böhm, Felix Mahfoud
Journal of the American Heart Association|December 1, 2023
Resting Heart Rate: A Valuable Marker for Preventing Kidney DiseaseAmr Abdin, Michael Böhm
Pageof 125

Showing results (1-10 of 1,247) with videos related to

Sort By:
Pageof 125
The American Journal of Cardiology|September 12, 2007
Angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors: where do we stand now?Michael Böhm
Herz|May 25, 2002
[Pathophysiology of heart failure today]Michael Böhm
MMW Fortschritte Der Medizin|November 8, 2003
[Therapy of heart failure. Which patients does the AT1 blocker help?]Michael Böhm
European Journal of Heart Failure|December 6, 2016
Heart rate: from heart failure to chronic diseases and cancer. Is there a role for supportive care by heart rate reduction?Michael Böhm
MMW Fortschritte Der Medizin|June 25, 2014
[Interview with Prof. Dr. med. Michael Böhm: lessons from SYMPLICITY HTN-3. "Denervation only within the scope of studies or registries" (interview by Dr. med. Dirk Einecke)]Michael Böhm
MMW Fortschritte Der Medizin|September 26, 2006
[Dyspnea in an ex-farmer]Oliver Weingärtner, Michael Böhm
Journal of the American College of Cardiology|May 31, 2011
Targeting mitochondrial oxidative stress in heart failure throttling the afterburnerChristoph Maack, Michael Böhm
MMW Fortschritte Der Medizin|March 25, 2022
[What the primary care physician can and should do initially in the practice when heart failure is suspected?]Amr Abdin, Michael Böhm
European Heart Journal|September 12, 2018
High blood pressure in coronary artery disease: when to start treating and what to target?Michael Böhm, Felix Mahfoud
Journal of the American Heart Association|December 1, 2023
Resting Heart Rate: A Valuable Marker for Preventing Kidney DiseaseAmr Abdin, Michael Böhm
Pageof 125